Role of peripheral myelin protein 22 in chronic exercise‐induced interactions of muscle and bone in mice

Kawaguchi, Miku; Kawao, Naoyuki; Muratani, Masafumi; Takafuji, Yoshimasa; Ishida, Masaharu; Kinoshita, Yuko; Takada, Yuto; Mizukami, Yuya; Ohira, Takashi; Kaji, Hiroshi

doi:10.1002/jcp.30706

Cited by 3 publications

(1 citation statement)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We previously revealed that irisin, follistatin, dickkopf 2, and peripheral myelin protein 22 produced by the skeletal muscles are related to the bone changes induced by changes in mechanical stress and gravity levels or exercise 9 − 13 . On the other hand, a diabetic state, vitamin D deficiency, and glucocorticoid excess suppress the expressions of several myokines, including irisin, IGF-1, and FGF2, in the skeletal muscles of mice 14 15 .…”

Section: Introductionmentioning

confidence: 99%

Effects of Growth Hormone on Muscle and Bone in Female Mice: Role of Follistatin

Ohira

Kawao

Takafuji

et al. 2022

Exp Clin Endocrinol Diabetes

Self Cite

View full text Add to dashboard Cite

The interactions between muscle and bone are noted for the clinical relationships between sarcopenia and osteoporosis. Myokines secreted from the skeletal muscles play roles in the muscle-bone interactions related to various physiological and pathophysiological states. Although numerous evidence suggested that growth hormone (GH) influences both muscle and bone, the effects of GH on the muscle-bone interactions have remained unknown. We therefore investigated the influences of GH administration for 8 weeks on muscle and bone, including myokine expression, in mice with or without ovariectomy (OVX). GH administration significantly increased muscle mass in the whole body and lower limbs, as well as tissue weights of the extensor digitorum longus (EDL) and soleus muscles, in mice with or without OVX. Moreover, it markedly increased grip strength in both mice. As for femurs, GH administration significantly increased cortical thickness and area in mice with or without OVX. Moreover, GH significantly blunted the decrease in the ratio of bone volume to tissue volume at trabecular bone in mice with OVX. GH administration significantly decreased follistatin mRNA levels in the EDL, but not the soleus, muscles in mice with or without OVX, although it did not affect the other myokines examined. However, GH administration significantly elevated serum follistatin levels in mice. In conclusion, our study indicated that GH administration increases skeletal muscle mass and grip strength, as well as cortical and trabecular bone-related parameters obtained by µCT analyses, in mice. However, myokine regulation might not be critical for the effects of GH on muscle and bone.

show abstract